Selective Inhibition of Vaccinia Virus by the Antibiotic Rifampicin
Authors:
- E. HellerEHE. Heller
- M. ArgamanMAM. Argaman
- H. LevyHLH. Levy
- N. GoldblumNGN. Goldblum
- 19 April 1969
- journal article
- Published by Springer Nature in Nature
- Vol. 222 (5190) , 273-274
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Rifamycins LXI: In vivo inhibition of RNA synthesis by rifamycinsCellular and Molecular Life Sciences, 1968
- Mutant of E. coli containing an Altered DNA-dependent RNA PolymeraseNature, 1968
- Growth of bacteriophage f2 in E. coli treated with rifampicin.Proceedings of the National Academy of Sciences, 1968
- Action of rifamycins on RNA polymeraseBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1968
- INHIBITION OF DNA-DEPENDENT RNA SYNTHESIS BY RIFAMYCINSThe Journal of Antibiotics, 1968
- The specific inhibition of the DNA-directed RNA synthesis by rifamycinBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1967
- Poxvirus DNA-dependent RNA polymerase.Proceedings of the National Academy of Sciences, 1967
- Rifampicin: A New Orally Active RifamycinChemotherapy, 1966
- Action of Rifamycin on Incorporation of Amino-acids into Protein in Cell-free Systems from B. subtilisNature, 1964